1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Recently released market study: Canada Pharmaceuticals & Healthcare Report Q3 2011

New Healthcare research report from Business Monitor International is now available from Fast Market Research

PRLog - Jul. 4, 2011 - BMI View: The Canadian pharmaceutical market is a refuge for the leading drugmakers. It is highly unlikely that punitive price controls like those witnessed across Europe over the past two years will be introduced. The market is also underpinned by political stability, unlike many emerging markets, and a recovering economy. However, healthcare reform places downward pressure on margins and patent expiries will compress headline growth. Unique attributes include a highly liberalised advertising environment and a culture of over-medication.

Headline Expenditure Projections

*  Pharmaceuticals: CAD25.75bn (US$24.76bn) in 2010 to CAD26.77bn (US$27.04bn) in 2011; +4.0% growth in local currency terms and +9.2% growth in US dollar terms. Forecast has been revised up moderately from Q211 due to macroeconomic factors.
 *  Healthcare: CAD177.14bn (US$170.32bn) in 2010 to CAD183.21bn (US$185.06bn) in 2011; +3.4% growth in local currency terms and +8.7% growth in US dollar terms. Forecast has been revised down moderately due to analyst intervention.
 *  Medical devices:CAD6.60bn (US$6.35bn) in 2010 to CAD7.02bn (US$7.09bn) in 2011; +6.3% growth in local currency terms and +11.7% growth in US dollar terms. Forecast has been revised moderately due to macroeconomic factors.

Full Report Details at
- http://www.fastmr.com/prod/205387_canada_pharmaceuticals_...

Business Environment Rating: In BMI's Business Environment Ratings (BERs) for Q311, Canada remains in second place in the expanded regional matrix, trailing the US by nearly eight points. The ratings criteria serve to reinforce our estimation of the country's potential, owing to a stronger emphasis on the regulatory environment, which we see as a major factor affecting the business environment for drugmakers. However, cost-containment pressures at both federal and provincial level will continue to pose an issue to manufacturers of novel products.

Key Trends & Developments

*  In May 2011, Pfizer Canada's president, Paul Levesque, demanded that Canada's intellectual property (IP) laws align with European and US standards and allow for patent term restoration (PTR). He also said that drug companies should have the right to appeal when they lose patent challenges. While drugmakers have hinted that stronger intellectual property protection will result in greater research and development (R&D) investment, a report by BMI in January 2011 found the claims to be untrue. Canada's IP rights have increased over the last 20 years, but R&D spending has actually declined to its lowest levels during the same period.

In May 2011, Canada's Valeant Pharmaceutical announced that it is to acquire Lithuania-based AB Sanitas for about EUR314mn (US$442.9mn) in cash, to expand its European branded generics product portfolio.

BMI Economic View: Our Canadian real GDP growth forecast for 2011 has been bumped up substantially to 2.9% from 2.4%. This is mainly as a result of an improved outlook for exports and business investment, and in spite of a slightly less ebullient outlook for the consumer.

BMI Political View: Canada has one of the highest long-term political ratings in the world, reflecting the country's history of stable governance and strong institutions. Nevertheless, Canada faces political challenges over the coming decade, including increasing regionalism and a potential shift in power from east to west.

Partial Table of Contents:

SWOT Analysis
- Canada Pharmaceuticals And Healthcare Industry SWOT
- Canada Political SWOT
- Canada Economic SWOT
Pharmaceutical Business Environment Ratings
- Table: Americas - Pharmaceuticals Business Environment Ratings, Q311
- Rewards
- Risks
Canada - Market Summary
Regulatory Regime
- Pharmacovigilance
- International Collaboration
Intellectual Property Regime
Pricing Regime
- Reimbursement Regime
- Recent Pricing and Reimbursement Developments
Industry Developments
- Epidemiology
- Healthcare Sector
- Table: Sustainability Of Public Health Expenditure And Pharmaceutical Approval Indicators
- National Pharmaceuticals Strategy
- Pharmaceutical Retail
- Research and Development Sector
- Biotechnology
- Medical Devices Industry
- Recent Developments in the Medical Devices Industry
Industry Forecast Scenario
- Overall Market Forecast
- Table: Pharmaceutical Sales Indicators 2007-2015
- Key Growth Factors - Industry
- Table: Healthcare Expenditure Indicators 2007-2015
- Table: Government Healthcare Expenditure Indicators 2007-2015
- Table: Private Healthcare Expenditure Indicators 2007-2015
- Key Growth Factors - Macroeconomic
- Table: Canada - GDP Contribution To Growth
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2007-2015
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators 2007-2015
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators 2007-2015
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales Indicators 2007-2015
- Medical Device Market Forecast
- Table: Medical Devices Sales Indicators 2007-2015
- Pharmaceutical Trade Forecast
- Table: Exports Indicators 2007-2015
- Table: Imports Indicators 2007-2015
- Other Healthcare Data
Competitive Landscape
- Pharmaceutical Industry
- Pharmaceutical Re-import Policy
- Recent Pharmaceutical Company Developments
- Top 20 Pharmaceutical Companies According To Market Capitalisation On The Canadian Stock Exchange
Company Profiles
- Domestic Manufacturers
- Apotex
- Biovail (Valeant)
- Leading Multinational Manufacturers
- Pfizer
- GlaxoSmithKline

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=2053...

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

--- End ---

Click to Share

Contact Email:
***@fastmr.com Email Verified
Source:Fast Market Research
State/Province:Massachusetts - United States
Industry:Health, Medical, Research
Tags:drug, generic, patented, Healthcare, medicines, pharmaceutical, regulatory, ratings, currency, prescription
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
Click to Share